| Typicality: | 0.503 |
| Saliency: | 0.394 |
| for ebola virus disease | 6 | transitive-object |
| on a small group of patients | 4 | location |
| against placebo | 3 | other |
| trial → test → new treatments | 18 |
| trial → test → new treatment | 11 |
| trial → study → new treatments | 3 |
| trial → evaluate → experimental treatment | 3 |
| negative | neutral | positive |
| 0.091 | 0.733 | 0.176 |
| Raw frequency | 35 |
| Normalized frequency | 0.394 |
| Modifier score | 0.760 |
| Perplexity | 377.522 |